The objective of this study was to analyze the effect of supplementation with creatine and glutamine on physical fitness of military police officers. Therefore, an experimental double blind study was developed, with the final sample composed by 32 men randomly distributed into three groups: a group supplemented with creatine (n=10), glutamine (n=10) and a placebo group (n=12) and evaluated in three distinct moments, in an interval of three months (T1, T2 and T3). The physical training had a weekly frequency of 5 sessions × 90 min, including strength exercises, local muscular resistance, flexibility and both aerobic and anaerobic capacity. After analyzing the effect of time, group and interaction (group × time) for measures that indicated the physical capabilities of the subjects, a significant effect of time for the entire variable was identified (p<0,05). However, these differences were not observed when the univaried intragroups and intergroups analysis was performed (p>0,05). In face of the results it was concluded that supplementation with creatine and glutamine showed no ergogenic effect on physical performance in military police officers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332172 | PMC |
| http://dx.doi.org/10.2478/hukin-2014-0098 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The effect of Sarcomeal® oral supplementation plus vitamin D3 on muscle parameters and metabolic factors in diabetic sarcopenia patients: study protocol of a randomized controlled clinical trial.
Trials
December 2024
Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Background: Diabetes is a significant risk factor for sarcopenia, a muscle dystrophy affecting older individuals. Sarcopenia management typically involves resistance exercise and oral supplements. Given the limitations of resistance training for many elderly individuals, oral supplements play a crucial role in treatment.
View Article and Find Full Text PDFFast High-Resolution Metabolite Mapping in the rat Brain Using H-FID-MRSI at 14.1 T.
NMR Biomed
February 2025
CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
Magnetic resonance spectroscopic imaging (MRSI) enables the simultaneous noninvasive acquisition of MR spectra from multiple spatial locations inside the brain. Although H-MRSI is increasingly used in the human brain, it is not yet widely applied in the preclinical setting, mostly because of difficulties specifically related to very small nominal voxel size in the rat brain and low concentration of brain metabolites, resulting in low signal-to-noise ratio (SNR). In this context, we implemented a free induction decay H-MRSI sequence (H-FID-MRSI) in the rat brain at 14.
View Article and Find Full Text PDFElevated posterior insula glutamate in patients with sickle cell disease.
J Pain
November 2024
Department of Anesthesia, Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Hematology/Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. Electronic address:
Article Synopsis
- Sickle cell disease (SCD) is a genetic condition that leads to chronic pain and episodes called vaso-occlusive crises (VOCs), and this study investigates how certain brain chemicals are altered in patients with SCD.
- Using proton magnetic resonance spectroscopy, researchers measured levels of glutamate and glutamine (Glx) in the right posterior insula cortex of individuals with SCD and healthy controls, finding significantly higher Glx levels in SCD patients, along with notable correlations between Glx levels, VOC frequency, and pain sensitivity.
- These findings suggest that an imbalance in excitatory neurotransmitters like glutamate in the insula may play a role in the pain experienced by SCD patients, highlighting the need for further
Plasma metabolic profile reveals signatures of maternal health during gestational hypertension and preeclampsia without and with severe features.
PLoS One
November 2024
Department of Biophysics and Pharmacology, Institute of Biosciences of Botucatu, Sao Paulo State University (UNESP), Botucatu, SP, Brazil.
Preeclampsia, a pregnancy-specific syndrome, poses substantial risks to maternal and neonatal health, particularly in cases with severe features. Our study focuses on evaluating the impact of low molecular weight metabolites on the intricate mechanisms and pathways involved in the pathophysiology of preeclampsia when severe features are present. We aim to pinpoint the distinct metabolomic profile in maternal plasma during pregnancies affected by hypertensive disorders and to correlate the metabolite levels with the clinical characteristics of the study cohort.
View Article and Find Full Text PDFSerum metabolomics signature of maternally inherited diabetes and deafness by gas chromatography-time of flight mass spectrometry.
J Diabetes Investig
January 2025
Department of Endocrinology & Metabolism, Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Article Synopsis
- The study aimed to identify a distinct metabolic signature for MIDD (Maternally Inherited Diabetes and Deafness) compared to healthy controls and other diabetes types.
- Researchers conducted serum metabolomic analysis using advanced technology with four groups: MIDD, LADA, type 2 diabetes, and healthy controls, all matched for age and gender.
- Results showed significant metabolic differences in MIDD, including high levels of certain carbohydrates and fatty acids, which could help better understand the disease's mechanisms.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!